Integra LifeSciences Holdings Corp (IART) reported third quarter net income attributable to diluted shares of $14.33 million or $0.49 per share, compared to net loss of $16.86 million or $0.60 per share last year.
Adjusted net income for the quarter was $15.6 million, or $0.53 per share, compared to $13.3 million, or $0.45 per share in the prior year quarter.
On average, 12 analysts polled by Thomson Reuters expected the company to report earnings of $0.52 per share. Analysts' estimates typically exclude special items.
Total revenues grew to $172.29 million from $167.03 million in the same quarter last year. Eleven analysts estimated revenues of $170.50 million.
The Company is updating its GAAP earnings per share guidance and reiterating its revenue and adjusted earnings per share guidance for the full year 2009. The Company continues to anticipate revenues between $680 million and $700 million and adjusted earnings per share between $2.00 and $2.20. The Company now anticipates GAAP earnings per share of between $1.59 and $1.79, compared to prior range between $1.64 and $1.84
Analysts expect the company to earn $2.11 per share, on revenues of $681.61 million.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.